Home/ Supplements/ Boswellia/ Saloxicin

Saloxicin

product on market Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Salicin and Boswellia serrata extract have moderate evidence for supporting joint health and reducing inflammation. The BerryVin blend provides antioxidants to combat oxidative stress. Overall, clinical evidence for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Saloxicin
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Salicin
120 mg
Market median: 375.0mg (171 products) 31 studies (A:1, B:14)
BerryVin High ORAC Berry Blend
40 mg

Other Ingredients

Hypromellose Water Tricalcium Phosphate Microcrystalline Cellulose Stearic Acid Magnesium Stearate Calcium Silicate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: take 2 capsules twice daily, or use as directed by your healthcare professional.

Warnings & Precautions

Consult your healthcare professional prior to use.

Individuals taking medication should discuss potential interactions with their healthcare professional.

Do not use if tamper seal is damaged.

Storage: keep tightly closed in a cool, dry place out of reach of children.

Formulation Notes

Saloxicin is formulated to support eicosanoid and cytokine balance and provide support for joint comfort. 5-LOXIN, a patented extract of Boswellia serrata standardized to 30% 3-O-acetyl-11-keto-B-boswellic acid (AKBA), is found to inhibit the 5-lipoxygenase enzyme. Salicin from white willow bark is a natural inhibitor of both the COX-2-2 and 5-lipoxygenase 5-1 enzymes. Bioflavonoid-rich BerryVin provides additional support for eicosanoid balance and antioxidant activity.

Formulated to exclude: wheat, gluten, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMO's), artificial colors, and artificial sweeteners.

Vegetarian caps

Salix alba/Boswellia serrata

Additional Information

Storage: keep tightly closed in a cool, dry place out of reach of children.

Third-party GMP compliant verified

Scan to learn

Metadata

Product Details

UPC / SKU8 71149 00032 5
DSLD Entry Date2025-07-24
Product TypeOther Combinations
FormCapsule
BrandXYMOGEN
DSLD ID335563
Data Updated2026-04-11
Research

Research Evidence

33
Research Sources
55
Avg Quality
17
Systematic Review
12
Meta Analysis
3
Rct
1
Clinical Trial
A Oral herbal therapies for treating osteoarthritis
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis
Meta Analysis Seminars in arthritis and rheumatism 2018 PubMed DOI
B Evaluating the efficacy and safety of Curcuma longa, Boswellia serrata, and their mixed formulation in treating knee osteoarthritis: A systematic review and network meta-analysis
Systematic Review Complementary therapies in medicine 2026 PubMed DOI
B Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis
Meta Analysis BMC complementary medicine and therapies 2020 PubMed DOI
B Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis
Systematic Review Frontiers in pharmacology 2022 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
B Ayurvedic interventions for osteoarthritis: a systematic review and meta-analysis
Meta Analysis Rheumatology international 2015 PubMed DOI
B Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis
Meta Analysis Phytotherapy research : PTR 2017 PubMed DOI
B Frankincense: systematic review
Systematic Review BMJ (Clinical research ed.) 2008 PubMed DOI
View all evidence for Boswellia →
Compare

Similar Products

View all Boswellia products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.